UniSuper Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$586K Sell
30,024
-21,800
-42% -$432K ﹤0.01% 559
2026
Q1
$997K Buy
51,824
+3,400
+7% +$67K 0.01% 545
2025
Q4
$917K Sell
48,424
-18,400
-28% -$341K 0.01% 549
2025
Q3
$1.25M Hold
66,824
0.01% 552
2025
Q2
$1.23M Hold
66,824
0.01% 555
2025
Q1
$1.17M Buy
66,824
+2,100
+3% +$35.4K 0.01% 546
2024
Q4
$1.12M Hold
64,724
0.01% 538
2024
Q3
$1.2M Hold
64,724
0.01% 554
2024
Q2
$997K Sell
64,724
-1,100
-2% -$15.7K 0.01% 583
2024
Q1
$972K Hold
65,824
0.01% 550
2023
Q4
$939K Hold
65,824
0.01% 265
2023
Q3
$918K Hold
65,824
0.01% 269
2023
Q2
$775K Buy
+65,824
New +$749K 0.01% 280

Other funds holding SBRA

UniSuper Management's SBRA Position: Q2 2026 in Review

UniSuper Management reduced its Sabra Healthcare REIT (SBRA) stake by 42% in Q2 2026, selling an estimated $432K and leaving 30,024 shares worth $586K. The position accounts for ﹤0.01% of the portfolio, ranked #559.

UniSuper Management first reported a position in SBRA in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.25M in Q3 2025. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • UniSuper Management held 30,024 shares of Sabra Healthcare REIT worth $586K as of Q2 2026.
  • UniSuper Management sold 21,800 Sabra Healthcare REIT shares in Q2 2026, an estimated $432K.
  • Sabra Healthcare REIT made up ﹤0.01% of UniSuper Management's portfolio in Q2 2026, its #559 holding.
  • UniSuper Management first reported a position in Sabra Healthcare REIT in Q2 2023 and has held it in 13 quarters since.
  • UniSuper Management's Sabra Healthcare REIT position peaked at $1.25M in Q3 2025.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.